T-ALL
Clinical trials for T-ALL explained in plain language.
Never miss a new study
Get alerted when new T-ALL trials appear
Sign up with your email to follow new studies for T-ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia: isatuximab trial opens for relapsed T-ALL
Disease control Recruiting nowThis study tests a drug called isatuximab in adults with a type of leukemia (T-ALL) that has come back or not responded to standard treatment. The goal is to see if adding isatuximab can help achieve remission or clear remaining cancer cells. About 40 participants will receive th…
Matched conditions: T-ALL
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
Engineered immune cells take aim at childhood leukemia in new trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD123-CAR T cells for children and young adults (up to age 21) with certain types of leukemia or related blood cancers that have come back or not responded to standard therapy. The treatment involves collecting the patient's own…
Matched conditions: T-ALL
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC